Phase II Committee on Ranking FDA Product Categories Based on Health Consequences profile picture

Phase II Committee on Ranking FDA Product Categories Based on Health Consequences

Is this your author profile? Create an account to claim and customize it!

Stand Alone

Risk-Characterization Framework for Decision-Making at the Food and Drug Administration